it's well documented and SI has mentioned this, that aGvhd is a priority. MSB need to focus on getting Ryoncil approved.
That's when the SP jumps back to high $5 in no time. Approval is the big kicker. Why, apart from aGvhd, we have three other products to do one more trial. Heart, Back and ARDS. $$$$$$$billions$$$$$$
This is so obvious. But, yes a big but, need approval. This is the risk\/reward we are talking about.
I'm done! Going to the footy!
it's well documented and SI has mentioned this, that aGvhd is a...
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.729B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5951 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 133644 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |